These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 662655)

  • 1. [The influence of rifampicin upon the metabolism of isoniazid (author's transl)].
    Modai J; Coulaud JP; Vivien JM; Berthelot G; Bergogne-Berezin E
    Nouv Presse Med; 1978 Apr; 7(15):1263-7. PubMed ID: 662655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Modification during treatment of the rate of acetylation of isoniazide clinically or biologically detectable hepatic damage (author's transl)].
    Albengres E; Houin G; Breau JL; Hirsch A; Saltiel JC; Tillement JP; Chrétien J
    Nouv Presse Med; 1977 Oct; 6(32):2869-71. PubMed ID: 917803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predisposing factors in hepatitis induced by isoniazid-rifampin treatment of tuberculosis.
    Grönhagen-Riska C; Hellstrom PE; Fröseth B
    Am Rev Respir Dis; 1978 Sep; 118(3):461-6. PubMed ID: 707874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Plasma levels of rifampicin and isoniazid and serum levels of aminotransferases in combined tuberculostatic treatment (author's transl)].
    Knop P; Kindler U; Austerhoff A
    Dtsch Med Wochenschr; 1977 Dec; 102(52):1913-5. PubMed ID: 598300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Simultaneous study of the induction effect of rifampicin and the phenotype for acetylation of isoniazid in 21 patients with tuberculosis undergoing a combination treatment].
    Chailleux E; Ordronneau J; Le Normand Y; Kergueris MF; Larousse C
    Rev Fr Mal Respir; 1980; 8(3):219-24. PubMed ID: 7187065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antibacterian activity modifications of serum isoniazid when using it with rifampicin (author's transl)].
    Nouhouayi A; Bergogne-Berezin E; Lafaix C
    Pathol Biol (Paris); 1982 Jun; 30(6):389-93. PubMed ID: 7050848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of isoniazid-metabolizing enzyme genotypes and isoniazid-induced hepatotoxicity in tuberculosis patients.
    Sotsuka T; Sasaki Y; Hirai S; Yamagishi F; Ueno K
    In Vivo; 2011; 25(5):803-12. PubMed ID: 21753138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [New information on the metabolism of isoniazide and rifampicin. Their therapeutical consequences (author's transl)].
    Sauvaget J; Sainte-Laudy J; Canavate A
    Poumon Coeur; 1979; 35(5):287-92. PubMed ID: 537976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Relationship between rate of inactivation of isoniazid and changes in transaminase levels during combined isoniazid-rifampicin therapy (author's transl)].
    Sehm G; Urbanczik R
    Prax Pneumol; 1974 Nov; 28(11):613-5. PubMed ID: 4453525
    [No Abstract]   [Full Text] [Related]  

  • 10. Serum transaminase levels in pulmonary tuberculosis. Effect of triple treatment with 4-4 1-di-isoamyloxythiocarbanilide or PAS in combination with streptomycin and isoniazid.
    Ockerman PA; Ryde C
    Scand J Respir Dis; 1968; 49(1):35-41. PubMed ID: 5187250
    [No Abstract]   [Full Text] [Related]  

  • 11. [Liver toxicity of combined rifampicin-isoniazid-ethambutol medication (author's transl)].
    Austerhoff A; Kindler U; Knop P; Knieriem HJ
    Dtsch Med Wochenschr; 1974 May; 99(22):1182 p. PubMed ID: 4835559
    [No Abstract]   [Full Text] [Related]  

  • 12. The disposition of antituberculous drugs in plasma of elderly patients. I. Isoniazid and hydrazine metabolite.
    Walubo A; Chan K; Woo J; Chan HS; Wong CL
    Methods Find Exp Clin Pharmacol; 1991 Oct; 13(8):545-50. PubMed ID: 1956209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Biotransformation of rifampicin in pulmonary tuberculosis patients].
    Ioffe RA
    Antibiotiki; 1977; 22(2):177-80. PubMed ID: 558736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The activity of transaminases (GOT and GPT), alkaline phosphatase and gamma-glutamyl transferases in the serum of patients treated with Rifampicin (author's transl)].
    Krstić-Burić M; Arko K; Rusan A; Mance D
    Plucne Bolesti Tuberk; 1980; 32(3):132-8. PubMed ID: 6110213
    [No Abstract]   [Full Text] [Related]  

  • 15. [Therapy of tuberculosis with Rifampicin in childhood (author's transl)].
    Simon K
    Med Klin; 1975 Jun; 70(25):1095-7. PubMed ID: 1083476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrinogen and antithrombin III blood levels fluctuations during isoniazid or isoniazid plus rifampicin administration.
    Farmakis M; Travlou O; Aroni S; Fertakis A
    Arzneimittelforschung; 1992 Aug; 42(8):1041-4. PubMed ID: 1418078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacodynamic interference between rifampicin and isoniazid.
    Llorens J; Serrano RJ; Sanchez R
    Chemotherapy; 1978; 24(2):97-103. PubMed ID: 620612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clearance of theophylline is increased during the initial period of tuberculosis treatment.
    Ahn HC; Lee YC
    Int J Tuberc Lung Dis; 2003 Jun; 7(6):587-91. PubMed ID: 12797703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of treatment of latent tuberculosis infection in compensated cirrhotic patients during transplant candidacy period.
    Jahng AW; Tran T; Bui L; Joyner JL
    Transplantation; 2007 Jun; 83(12):1557-62. PubMed ID: 17589337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.